TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36054685

Group type: EXPERIMENTAL
Intervention: Video-based eLearning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Slide-based eLearning
Number of subjects: 0
Study: 34243157

Group type: EXPERIMENTAL
Intervention: Endoscopic third ventriculostomy plus choroid plexus cauterization (ETV+CPC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ventriculoperitoneal shunt (VPS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both ETV+CPC and VPS (analyzed together)
Number of subjects: 100
Study: 33354337

Group type: COMPARATOR
Intervention: Weight Watchers (WW) online platform alone
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Weight Watchers (WW) enhanced with Experience Success (WW + ES) programme
Number of subjects: 146
Study: 35925531

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention for NF
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: NF1
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: SCHW
Number of subjects: 228
Study: 32183345

Group type: EXPERIMENTAL
Intervention: Compliance with the 2018 WCRC/AICR cancer prevention recommendations
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Limiting consumption of fast foods, sugar-sweetened drinks, and alcohol
Number of subjects: 398
Study: 33849382

Group type: COMPARATOR
Intervention: Intralesional triamcinolone (Group-A, control)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intralesional verapamil (Group-B)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intralesional 5-fluorouracil (Group-C)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intralesional platelet-rich plasma (Group-D)
Number of subjects: 160
Study: 32347414

Group type: EXPERIMENTAL
Intervention: Retention strategies used to facilitate participant engagement in follow‐up assessments
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: High school diploma
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Recruitment at community centers
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Less severe mental health condition
Number of subjects: 341
Study: 32170727

Group type: EXPERIMENTAL
Intervention: Web-based written information and information to doctor recommending smoking cessation (group 4)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (no specific information)
Number of subjects: 376
Study: 34259328

Group type: EXPERIMENTAL
Intervention: Core exercise training (Ex)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Whole-body vibration with core exercise (WBVEx)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 34127609

Group type: EXPERIMENTAL
Intervention: Change-of-direction technique modification intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal training (control group)
Number of subjects: 27
Study: 32331036

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray + oral antidepressant (ESK+AD)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Oral antidepressant + placebo nasal spray (AD+PBO)
Number of subjects: 223
Study: 36279133

Group type: EXPERIMENTAL
Intervention: Contextualized clinical decision support (CDS) tools in the electronic health record (EHR)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Contextualized care plans
Number of subjects: 452
Study: 33601736

Group type: EXPERIMENTAL
Intervention: High depression symptom severity (dichotomized)
Number of subjects: 722

Group type: COMPARATOR
Intervention: DASS total or subscale scores
Number of subjects: 722

Group type: COMPARATOR
Intervention: Persistence of high DASS symptom severity
Number of subjects: 722
Study: 32515747

Group type: EXPERIMENTAL
Intervention: Tablet app-based dexterity training (TAD-MS) for 4 weeks, five times a week, 30 minutes per session.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Tablet app-based dexterity training (TAD-MS)
Number of subjects: 9
Study: 35052995

Group type: EXPERIMENTAL
Intervention: Biorepair Parodontgel Intensive (postbiotics-based)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Curasept Periodontal Gel (chlorhexidine-based)
Number of subjects: 30
Study: 32001213

Group type: EXPERIMENTAL
Intervention: Pooled non-control doses group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 33469717

Group type: EXPERIMENTAL
Intervention: 27-gauge needle (32 mm × 0.2 mm)
Number of subjects: 212

Group type: COMPARATOR
Intervention: 30-gauge needle (25 mm × 0.15 mm)
Number of subjects: 212
Study: 32131146

Group type: EXPERIMENTAL
Intervention: Soap
Number of subjects: 29

Group type: COMPARATOR
Intervention: Water
Number of subjects: 29
Study: 35738633

Group type: EXPERIMENTAL
Intervention: Bortezomib (1.3 mg/m2 subcutaneously on days 1, 4, 8, and 11) and Pegylated Liposomal Doxorubicin (40 mg/m2 intravenously on day 4), every 4 weeks
Number of subjects: 23
Study: 32955694

Group type: EXPERIMENTAL
Intervention: Gambling-MCT (Metacognitive Training)
Number of subjects: 25
Study: 32960539

Group type: EXPERIMENTAL
Intervention: Rectal biopsy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Rectal swab
Number of subjects: 24
Study: 34725764

Group type: EXPERIMENTAL
Intervention: Prehabilitation
Number of subjects: 54
Study: 33559433

Group type: EXPERIMENTAL
Intervention: Shao's five-needle therapy combined with conventional western medical treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional western medical treatment
Number of subjects: 80
Study: 32804024

Group type: EXPERIMENTAL
Intervention: Surgically implanted cryopreserved human umbilical cord allograft
Number of subjects: 21
Study: 35048892

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) in a group format
Number of subjects: 243

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 243
Study: 34587385

Group type: EXPERIMENTAL
Intervention: Ozanimod (1 mg once daily)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study: 34471610

Group type: EXPERIMENTAL
Intervention: Optimized UI (N = 198)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Basic UI (N = 199)
Number of subjects: 397
Study: 36123853

Group type: EXPERIMENTAL
Intervention: Nurse-led program intervention plus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34850160

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg once-daily
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 34308585

Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted total knee arthroplasty (RATKA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty (TKA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (RATKA and TKA)
Number of subjects: 60
Study: 33213398

Group type: EXPERIMENTAL
Intervention: Medical Dashboard eHealth self-management intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 36014777

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention for childhood obesity
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1176
Study: 32842112

Group type: EXPERIMENTAL
Intervention: Cranial vault remodeling surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control subjects (not specified)
Number of subjects: 20
Study: 35301858

Group type: EXPERIMENTAL
Intervention: Best Practice Alert (BPA)
Number of subjects: 1856

Group type: COMPARATOR
Intervention: No BPA
Number of subjects: 1856
Study: 33176796

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (SE and OE groups)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (SE group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (SC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 33892819

Group type: EXPERIMENTAL
Intervention: Low salicylate diet
Number of subjects: 7

Group type: COMPARATOR
Intervention: High salicylate diet
Number of subjects: 7
Study: 34158360

Group type: EXPERIMENTAL
Intervention: Cobimetinib plus vemurafenib
Number of subjects: 495

Group type: COMPARATOR
Intervention: Placebo plus vemurafenib
Number of subjects: 495
Study: 33035206

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) intervention, provided with 2 free finger-prick-based HIVST kits at enrollment and 2 to 4 kits every 3 months for 1 year, in addition to site-based HIV testing (SBHT)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group with access to site-based HIV testing (SBHT) only
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) intervention
Number of subjects: 230
Study: 35987996

Group type: COMPARATOR
Intervention: Propofol + saline (P group)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Propofol + esketamine 0.05 mg/kg (PK1 group)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Propofol + esketamine 0.1 mg/kg (PK2 group)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Propofol + esketamine 0.2 mg/kg (PK3 group)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 260
Study: 32204780

Group type: EXPERIMENTAL
Intervention: Interventions aligned with the Occupational Therapy Practice Framework: Domain and Process (3rd ed.)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Not applicable (no specific occupational therapy intervention mentioned)
Number of subjects: 35
Study: 35158065

Group type: EXPERIMENTAL
Intervention: Hook plate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Locking plate augmented with coracoclavicular fixation
Number of subjects: 30
Study: 34455684

Group type: EXPERIMENTAL
Intervention: PCOS (n=41,851)
Number of subjects: 41851

Group type: EXPERIMENTAL
Intervention: PCOS with severe hyperandrogenic profile (n=13,713)
Number of subjects: 41851

Group type: COMPARATOR
Intervention: Women without PCOS (n=241,750)
Number of subjects: 41851
Study: 35031487

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine-impregnated cloths
Number of subjects: 76815

Group type: EXPERIMENTAL
Intervention: 0.08% octenidine wash mitts
Number of subjects: 76815

Group type: COMPARATOR
Intervention: Routine care (water and soap)
Number of subjects: 76815
Study: 34279627

Group type: EXPERIMENTAL
Intervention: PVAC Gold
Number of subjects: 208

Group type: COMPARATOR
Intervention: ST-CF
Number of subjects: 208
Study: 33172557

Group type: EXPERIMENTAL
Intervention: Short-peptide enteral nutrition formula
Number of subjects: 68

Group type: COMPARATOR
Intervention: Intact-protein enteral nutrition formula
Number of subjects: 68
Study: 34128698

Group type: EXPERIMENTAL
Intervention: Training program with different tones
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Training program with the same tone preceding target words
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cantonese native speakers (reference group)
Number of subjects: 63
Study: 32350785

Group type: EXPERIMENTAL
Intervention: 4 units of FFP administered before separation from CPB and 4 units of FFP and 20 units of platelet concentrate administered after separation from CPB
Number of subjects: 30

Group type: COMPARATOR
Intervention: 8 units of FFP and 20 units of platelet concentrate administered after separation from CPB
Number of subjects: 30
Study: 33780264

Group type: EXPERIMENTAL
Intervention: Icotinib combined with concurrent chemoradiotherapy (CRT)
Number of subjects: 29
Study: 33963801

Group type: EXPERIMENTAL
Intervention: Training in LI-RADS
Number of subjects: 61
Study: 36216952

Group type: EXPERIMENTAL
Intervention: Resistance training with blood flow restriction (RTBFR), 30% intensity, 36 sessions over 12 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional resistance training (TRT), 80% intensity, 36 sessions over 12 weeks
Number of subjects: 14
Study: 34487664

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 122

Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 122
Study: 32960160

Group type: EXPERIMENTAL
Intervention: Non-periodized training (NG)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Linear periodization training (PG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 35
Study: 32448972

Group type: EXPERIMENTAL
Intervention: Shockpulse
Number of subjects: 119

Group type: COMPARATOR
Intervention: Pneumatic lithoclast
Number of subjects: 119
Study: 32532550

Group type: EXPERIMENTAL
Intervention: Right stellate ganglion block with 4mL of 0.2% ropivacaine under ultrasound guidance
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no stellate ganglion block)
Number of subjects: 200
Study: 36446221

Group type: EXPERIMENTAL
Intervention: Brain Balance@ exercises and Interactive Metronome@ training (BB/IM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (typically developing children)
Number of subjects: 16
Study: 34649850

Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for resuming CPAP use after discontinuation.
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for adherence to CPAP.
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for patient satisfaction.
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Peer‐driven intervention for feasibility and execution.
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (no peer‐driven intervention).
Number of subjects: 208
Study: 33830437

Group type: EXPERIMENTAL
Intervention: Metformin (target dose 1000 mg bid)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Lifestyle counseling (Control)
Number of subjects: 54
Study: 32268991

Group type: EXPERIMENTAL
Intervention: Herbal compound (500 mg of Plantago ovata husk in 30 mL water plus three drops of vinegar per dose, used as a mouthwash)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 28
Study: 32193071

Group type: EXPERIMENTAL
Intervention: Senior Simulation Suit Programme (SSSP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (placebo clothing)
Number of subjects: 139
Study: 34897958

Group type: EXPERIMENTAL
Intervention: Variolink Esthetic LC
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: IPS Empress Direct with ultrasonic vibration
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Ultrasonically vibrated Estelite Omega groups
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: IPS Empress Direct preheated and ultrasonically vibrated
Number of subjects: 126

Group type: COMPARATOR
Intervention: Composite resins (Estelite Omega)
Number of subjects: 126
Study: 32830913

Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated balloon (DCB)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Standard percutaneous transluminal angioplasty (PTA)
Number of subjects: 431
Study: 35006255

Group type: EXPERIMENTAL
Intervention: Intensive Vascular Care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 0
Study: 34096450

Group type: EXPERIMENTAL
Intervention: Fear appeal message
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Social norms message
Number of subjects: 378
Study: 35146797

Group type: EXPERIMENTAL
Intervention: Tegoprazan 50 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vonoprazan 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 16
Study: 33290394

Group type: EXPERIMENTAL
Intervention: RV144 vaccination
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34011436

Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitor monotherapy after 3-month DAPT
Number of subjects: 4453

Group type: COMPARATOR
Intervention: Conventional dual antiplatelet therapy (DAPT)
Number of subjects: 4453

Group type: COMPARATOR
Intervention: Aspirin monotherapy after 6-month DAPT
Number of subjects: 4453
Study: 33239950

Group type: EXPERIMENTAL
Intervention: CHO-M (CHO-electrolyte solution + MBI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (noncarbohydrate solution + traveling introduction audio)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CHO (Carbohydrate-electrolyte solution + traveling introduction audio)
Number of subjects: 14
Study: 34755312

Group type: EXPERIMENTAL
Intervention: Adapted ERAS group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 120
Study: 34303314

Group type: EXPERIMENTAL
Intervention: Hip-focused neuromuscular exercise
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham exercise
Number of subjects: 44
Study: 35304299

Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT) dressing for 7 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Occlusive dressing (control) for 7 days
Number of subjects: 120
Study: 33284113

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus axitinib
Number of subjects: 861

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 861
Study: 33413353

Group type: EXPERIMENTAL
Intervention: VHA healthcare providers
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: VHA smoking cessation medication use
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: VHA referral to smoking cessation services
Number of subjects: 366
Study: 32284049

Group type: EXPERIMENTAL
Intervention: Structured OA care model (physiotherapist-led education program and individually tailored exercises for 8-12 weeks)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Structured OA care model (exercise completers)
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Structured OA care model (exercise non-completers)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 393
Study: 35382960

Group type: EXPERIMENTAL
Intervention: Medication disposal pouch
Number of subjects: 221

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 221
Study: 33862313

Group type: EXPERIMENTAL
Intervention: Sativex (Nabiximols)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 35315909

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy for 6 weeks
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy for 3 months
Number of subjects: 178
Study: 33561507

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (RT quality graded as per protocol - PP)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (RT quality graded as minor deviation - MiD)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (RT quality graded as major deviation - MaD)
Number of subjects: 442
Study: 35332795

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Soy Milk Consumption (SMC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resistance Training + Soy Milk (RSM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 60
Study: 32293527

Group type: EXPERIMENTAL
Intervention: Optimised vancomycin regimen (loading dose of 25 mg/kg followed by 15 mg/kg q12h or q8h for 5 ± 1 days)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard vancomycin regimen (15 mg/kg q24h, q12h or q8h for 10 ± 2 days)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Optimised vancomycin regimen
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard vancomycin regimen
Number of subjects: 300
Study: 35332812

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33213420

Group type: EXPERIMENTAL
Intervention: Stagnant water body near a house
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Engaging in outdoor activities before dawn or after dusk
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Having a house with open eaves
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Wearing long-sleeved clothes when outdoors at night
Number of subjects: 63
Study: 35279948

Group type: EXPERIMENTAL
Intervention: HARD (Restylane Defyne with lidocaine)
Number of subjects: 173

Group type: COMPARATOR
Intervention: HAR (Restylane)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: HARD
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: HARD and HAR
Number of subjects: 173
Study: 32423943

Group type: EXPERIMENTAL
Intervention: Child survivors of PICU
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Parents of child survivors
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Siblings of child survivors
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Qualitative interviews with families
Number of subjects: 300
Study: 34215454

Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (100 µg adjuvanted)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (two doses of 50 µg adjuvanted)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (adjuvanted)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: GBS-NN vaccine (two doses of 50 µg)
Number of subjects: 240
Study: 32349638

Group type: EXPERIMENTAL
Intervention: Local anesthetic injection
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (no injection)
Number of subjects: 46
Study: 36163490

Group type: EXPERIMENTAL
Intervention: Early lens extraction surgery
Number of subjects: 12

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 12
Study: 34323448

Group type: EXPERIMENTAL
Intervention: Cooled radiofrequency ablation (CRFA)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Repeat CRFA
Number of subjects: 136
Study: 32687836

Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left IFG/LipM1 and cathodal tDCS to the right hemisphere homologue
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS over the left and anodal over the right
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All stimulation groups (Anodal, Cathodal, Sham)
Number of subjects: 60
Study: 36424914

Group type: EXPERIMENTAL
Intervention: iTClamp
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pressure dressing
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: iTClamp and Pressure dressing
Number of subjects: 20
Study: 34933545

Group type: EXPERIMENTAL
Intervention: New electromagnetic and vibrating device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alpha-blocker agents
Number of subjects: 0
Study: 34321096

Group type: EXPERIMENTAL
Intervention: Epratuzumab (monoclonal antibody targeting CD22)
Number of subjects: 0
Study: 32385848

Group type: EXPERIMENTAL
Intervention: Health Literacy (HL)
Number of subjects: 579